Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-20 Sale |
2025-03-24 4:35 pm |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
15,944 | $23.11 | $368,466 | 31,756 (Direct) |
View |
| 2025-03-17 Sale |
2025-03-19 5:53 pm |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
20,343 | $23.1 | $469,923 | 80,897 (Direct) |
View |
| 2025-03-12 Sale |
2025-03-14 4:37 pm |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
36,372 | $22.25 | $809,277 | 51,246 (Direct) |
View |
| 2024-12-06 Sale |
2024-12-10 4:34 pm |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
27,829 | $21.34 | $593,997 | 69,038 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-05 7:14 pm |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
15,116 | $21.37 | $323,009 | 111,030 (Direct) |
View |
| 2024-07-23 Sale |
2024-07-25 4:32 pm |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
24,248 | $24.79 | $601,108 | 59,665 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-04 4:30 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
12,000 | $20 | $240,000 | 15,632 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-07 Tax Withholding |
2025-04-09 4:45 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,303 | $20.28 | 29,192 (Direct) |
View |
| 2025-04-07 Exercise |
2025-04-09 4:45 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
2,694 | $0 | 29,192 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:04 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
3,342 | $0 | 85,007 (Direct) |
View |
| 2025-04-01 Tax Withholding |
2025-04-03 5:04 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,617 | $21.77 | 85,007 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 5:04 pm |
N/A 2035-03-31 |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
51,627 | $0 | 85,007 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-24 4:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
15,944 | $12.97 | 31,756 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-24 4:35 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
15,944 | $0 | 31,756 (Direct) |
View |
| 2025-03-17 Exercise |
2025-03-19 5:53 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
20,343 | $12.97 | 80,897 (Direct) |
View |
| 2025-03-16 Tax Withholding |
2025-03-19 5:53 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
448 | $22.61 | 80,897 (Direct) |
View |
| 2025-03-16 Exercise |
2025-03-19 5:53 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
21,215 | $0 | 80,897 (Direct) |
View |
| 2025-03-12 Exercise |
2025-03-14 4:37 pm |
N/A 2032-08-31 |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
36,372 | $0 | 51,246 (Direct) |
View |
| 2025-03-12 Exercise |
2025-03-14 4:37 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
36,372 | $11.97 | 51,246 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-10 4:34 pm |
N/A 2033-03-31 |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
21,266 | $0 | 69,038 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-10 4:34 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
2,406 | $10.76 | 69,038 (Direct) |
View |
| 2024-12-09 Exercise |
2024-12-10 4:34 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
18,860 | $11.1 | 69,038 (Direct) |
View |
| 2024-12-03 Exercise |
2024-12-05 7:14 pm |
N/A 2033-03-31 |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
15,116 | $0 | 111,030 (Direct) |
View |
| 2024-12-03 Exercise |
2024-12-05 7:14 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
15,116 | $10.76 | 111,030 (Direct) |
View |
| 2024-09-01 Exercise |
2024-09-04 8:51 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
10,749 | $0 | 74,972 (Direct) |
View |
| 2024-09-01 Option Award |
2024-09-04 8:51 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
39,515 | $0 | 74,972 (Direct) |
View |
| 2024-09-01 Tax Withholding |
2024-09-04 8:51 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
3,216 | $26.74 | 74,972 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-25 4:32 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
24,248 | $0 | 59,665 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-25 4:32 pm |
N/A N/A |
Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
24,248 | $11.1 | 59,665 (Direct) |
View |
| 2024-04-26 Tax Withholding |
2024-04-30 4:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
509 | $17.88 | 20,243 (Direct) |
View |
| 2024-04-26 Exercise |
2024-04-30 4:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
991 | $0 | 20,243 (Direct) |
View |
| 2024-04-08 Tax Withholding |
2024-04-08 5:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
791 | $17.9 | 77,549 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-08 5:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
2,694 | $0 | 77,549 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 5:20 pm |
N/A 2034-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
44,607 | $0 | 77,549 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 5:25 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
514 | $19.7 | 22,118 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 5:25 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,750 | $0 | 22,118 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
12,000 | $8.83 | 15,632 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:30 pm |
N/A 2029-09-16 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
12,000 | $0 | 15,632 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-06 7:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
4,556 | $0 | 76,486 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-06 7:06 pm |
N/A 2033-08-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
49,050 | $0 | 76,486 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-06 7:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,338 | $17.76 | 76,486 (Direct) |
View |
| 2023-04-26 Exercise |
2023-04-28 4:15 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
990 | $0 | 14,395 (Direct) |
View |
| 2023-04-26 Tax Withholding |
2023-04-28 4:15 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
291 | $11.15 | 14,395 (Direct) |
View |
| 2023-04-10 Exercise |
2023-04-11 5:04 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
2,695 | $0 | 19,797 (Direct) |
View |
| 2023-04-10 Tax Withholding |
2023-04-11 5:04 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
791 | $10.71 | 19,797 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-03 4:30 pm |
N/A 2033-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
49,050 | $0 | 49,050 (Direct) |
View |
| 2023-03-16 Exercise |
2023-03-20 5:14 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
3,030 | $0 | 11,555 (Direct) |
View |
| 2023-03-20 Tax Withholding |
2023-03-20 5:14 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
634 | $11.12 | 11,555 (Direct) |
View |
| 2023-03-16 Tax Withholding |
2023-03-20 5:14 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
256 | $11.46 | 11,555 (Direct) |
View |
| 2022-09-02 Tax Withholding |
2022-09-06 4:10 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
547 | $11.44 | 88,691 (Direct) |
View |
| 2022-09-02 Exercise |
2022-09-06 4:10 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,861 | $0 | 88,691 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:10 pm |
N/A 2032-08-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
75,437 | $0 | 88,691 (Direct) |
View |
| 2022-04-26 Exercise |
2022-04-28 4:31 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
991 | $0 | 9,328 (Direct) |
View |
| 2022-04-26 Tax Withholding |
2022-04-28 4:31 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
282 | $9.99 | 9,328 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-11 4:30 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
75,437 | $0 | 75,437 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
3,019 | $0 | 5,648 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,047 | $10.98 | 5,648 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 4:38 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer |
872 | $0 | 6,292 (Direct) |
View |
| 2022-03-16 Tax Withholding |
2022-03-18 4:38 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer |
303 | $10.13 | 6,292 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:18 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer |
52,105 | $0 | 52,105 (Direct) |
View |
| 2021-04-26 Option Award |
2021-04-28 5:31 pm |
N/A 2031-04-25 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO |
27,687 | $0 | 27,687 (Direct) |
View |
| 2021-03-20 Option Award |
2021-03-23 5:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO |
5,177 | $0 | 5,177 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:14 pm |
N/A 2031-03-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO |
24,413 | $0 | 24,413 (Direct) |
View |
| 2020-12-31 Exercise |
2021-01-05 5:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO |
4,404 | $0 | 3,107 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 5:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO |
1,297 | $17.67 | 3,107 (Direct) |
View |
Ownership |
2020-12-23 5:03 pm |
N/A 2028-05-22 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO |
0 | $0 | 108,703 (Direct) |
View |